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1  | INTRODUC TION
The global consumption of drugs to treat acute and chronic diseases 
continues to increase (WHO, 2011). Inevitably, healthcare profes-
sionals are frequently confronted with patients using one or more 
drugs on a daily basis. These drugs can cause several adverse effects 
in the oral region such as a sensation of oral dryness (xerostomia), 
hyposalivation, mucositis and taste disorders (Rademacher et al., 
2019). Due to the large number of drugs available and their wide 
range of adverse effects, it is difficult and time-consuming for 
healthcare professionals to take all the potential consequences into 
account during their daily practice. To support oral healthcare pro-
fessionals in their decision making, the Journal of Oral Diseases is 
publishing a series of articles discussing the most frequent adverse 
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Objectives: Due to a worldwide increase in drug consumption, oral healthcare pro-
fessionals are frequently confronted with patients using one or more drugs. A large 
number of drugs can be accompanied with adverse drug reactions in the orofacial 
region, amongst others of the tongue. This paper aims to give an overview of drugs 
that are known to be accompanied with tongue disorders.
Materials and methods: The national drug information database for Dutch pharma-
cists, composed of scientific drug information, guidelines and summaries of product 
characteristics, was analysed for drug-induced tongue disorders. “MedDRA classifi-
cation” and “Anatomical Therapeutic Chemical codes” were used to categorize the 
disorders.
Results: The database comprises of 1645 drugs of which 121 (7.4%) are documented 
to be accompanied with tongue disorders as an adverse effect. Drug-induced tongue 
disorders are predominantly observed in the following drug categories: “nervous sys-
tems,” “anti-infectives for systemic use” and “alimentary tract and metabolism”. The 
most common drug-induced tongue disorders are glossitis, tongue oedema, tongue 
discoloration and burning tongue.
Conclusion: Healthcare professionals are frequently confronted with drugs that can 
cause tongue disorders. The overview of drugs reported in this article supports clini-
cians in their awareness, diagnosis and treatment of drug-induced tongue disorders.
K E Y W O R D S
burning tongue, drug-induced tongue disorders, glossitis, tongue oedema, tongue 
discoloration
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© 2020 The Authors. Oral Diseases published by Wiley Periodicals LLC
2  |     AZIZ et Al.
effects of drugs in the oral region. The first paper discussed drug-in-
duced taste disorders (Rademacher et al., 2019). This paper focuses 
on drug-induced tongue disorders.
Tongue disorders, which are rather frequently observed, can be 
divided into congenital and acquired tongue disorders. Aglossia, an-
kyloglossia, hypoglossia, macroglossia, cleft tongue and glossoptosis 
are examples of congenital tongue disorders (Mangold et al., 2016). 
Drug-induced tongue disorders belong to the category acquired 
tongue disorders.
Several studies have reported cases of drug-induced tongue dis-
orders (Alharbi et al., 2018; Balaji et al., 2014; Braggio et al., 2018; 
Brown, 1949; Gurvits & Tan, 2014; Healy et al., 2004; Hubiche et al., 
2013; Kalogirou et al., 2017), but a comprehensive overview of 
drugs associated with tongue disorders as an adverse effect is not 
available. Such an overview will support oral healthcare providers in 
the recognition, diagnosis and eventual treatment of drug-induced 
tongue disorders.
2  | MATERIAL S AND METHODS
An elaborated description of the Materials and Methods used in the 
current study is described by Rademacher et al. (2019). In short, the 
data on oral adverse effects of medications were derived from the 
Informatorium Medicamentorum of the Royal Dutch Pharmacists 
Association (KNMP), the leading drug information database and 
reference work for pharmacists in the Netherlands (KNMP, 2019). 
This database is composed of scientific drug information, guide-
lines and summaries of product characteristics. It includes not 
only entries derived from scientific publications (randomized con-
trol trails, observational studies, case reports, etc.), but also data 
from the Netherlands pharmacovigilance centre LAREB, the Dutch 
knowledge centre for adverse drug reactions. The Informatorium 
Medicamentorum is regularly updated with the latest obtainable in-
formation from scientific publications, warnings of authorities and 
summaries of product characteristics of the European Medicines 
Agency and Medicines Evaluation Board in the Netherlands. The 
Informatorium Medicamentorum database was last searched on 1 
August 2018. All drugs of which was reported that they may cause 
tongue disorders were extracted from this database. For each drug, 
the following information was recorded: generic name of the drug, 
term of the adverse effect, incidence of the adverse effect and 
Anatomical Therapeutic Chemical (ATC) code of the drug (WHO, 
2003). The MedDRA classification was manually applied after the 
selection of drugs that have been linked to causing tongue disor-
ders (MedDRA, 2018a, 2018b). This system categorizes medical 
terminology in five levels. The “Lowest Level Term (LLT)” and the 
“Preferred Term (PT)” were used to categorize drug-induced tongue 
disorders (Rademacher et al., 2019). The most common definitions 
were used to describe drug-induced tongue disorders. Microsoft® 
Excel (version 16.16.1) was used to create a database with acquired 
information on drug-induced tongue disorders. Descriptive statistics 
were applied where applicable.
3  | RESULTS
The Informatorium Medicamentorum database comprises informa-
tion on 1645 drugs with approximately 65,000 unique combinations 
between a drug and an adverse effect as each drug can cause mul-
tiple adverse effects. About 2335 (3.5%) of these unique combina-
tions enclose adverse effects of medication in the orofacial region.
In total, 121 (7.4%) drugs out of the 1645 drugs have been as-
sociated with tongue disorders as adverse drug reaction (Table 1). 
Drug-induced tongue disorders are predominantly reported in the 
following drug categories: “nervous systems,” “anti-infectives for 
systemic use” and “antineoplastic and immunomodulating agents” 
(Table 2). The most common drug-induced tongue disorders are 
glossitis, tongue oedema, tongue discoloration and burning tongue.
A wide variety of terminology is found in the literature to de-
scribe a particular tongue disorder related to the use of a drug and 
vice versa. Some of these terms may even overlap each other. As it 
was not possible to identify the exact definitions that were used to 
denominate a reported adverse drug reaction by coders, we have 
chosen to categorize the drug-induced tongue disorders as follows:
1. Alteration in colour of the tongue (glossitis, tongue discolor-
ation, hairy tongue, coated tongue)
2. Increase in volume of the tongue (tongue oedema, hypertrophy of 
tongue papillae)
3. Alteration in sensitivity of the tongue (burning tongue, dysaesthe-
sia of tongue, pruritus of tongue, glossodynia, tongue numbness)
4. Defect of surface of the tongue ( tongue ulceration)
5. Other tongue disorders (tongue irritation, tongue disorders NOS)
TA B L E  1   Number of medications associated with particular 
tongue disorders




Dysaesthesia of tongue 2
Glossitis 36
Hairy tongue 4
Hypertrophy of tongue papillae 1
Pruritus of tongue 1
Glossodynia 6
Tongue disorders NOS* 5
Coated tongue 4






*NOS, not otherwise specified. 
     |  3AZIZ et Al.
3.1 | Alteration in colour of the tongue
In total, 36 (2.2% of 1645 drugs) drugs were associated with glossitis 
(Figure 1) as an adverse drug reaction (Table 1). Glossitis was defined 
as inflammation of the tongue with loss of filiform papillae, leading to 
pain, swelling and erythema (Byrd et al., 2003). It was reported in 10 
of the 14 ATC level 1 categories of the ATC classification. The drug cat-
egories “anti-infectives for systemic use” (36%) and “nervous systems” 
(13.9%) contain most medications that have been associated with glos-
sitis. Both categories account for almost 50% of drug-induced glossitis. 
Drug-induced glossitis is rather “common” in 11.1% (4 out of 36 drugs), 
“uncommon” in 41.7% (15 out of 36 drugs), “rare” in 30.5% (11 out of 
36 drugs) and “very rare” in 11.1% (4 out of 36 drugs) of the drugs. The 
frequency of occurring of glossitis was not reported for methotrexate.
In the Informatorium Medicamentorum database, 21 drugs (1.28 
% of 1645 drugs) were associated with the development of tongue 
discoloration (Figure 2) as an adverse drug reaction. Tongue discol-
oration was defined as pigmentation of the tongue as a result of the 
drug or its metabolites deposition or by increasing the production 
of melanin. The discoloration may be blue, brown, grey or black 
(Rosebush et al., 2019). Tongue discoloration was reported in 7 of 
the 14 ATC level 1 categories. Tongue discoloration was predomi-
nantly reported in the drug categories “anti-infectives for systemic 
use” (52.4%) and “dermatologicals” (19%). Frequency of drug-in-
duced tongue discoloration was “uncommon” in 19% (4 out of 21 
drugs), “rare” in 14.3% (3 out of 21 drugs), “very rare” in 47.6% (10 out 
of 21 drugs) and “unknown” in 19% (4 out of 21 drugs) of the drugs.
Hairy tongue is a transitory and harmless condition character-
ized by hypertrophy and prolongation of filiform papillae on the 
surface of the tongue (Figure 3). The colour of the tongue can vary 
from yellow to brown or black (Reamy et al., 2010). Hairy tongue as 
an adverse effect was reported for 4 drugs (0.24% of 1645 drugs). 
Two of these drugs belong to the drug category “anti-infectives for 
systemic use.” Coated tongue describes any area of the tongue with 
a coating on it. Coated tongue as an adverse effect was reported for 
4 drugs (0.24% of 1645 drugs). These 4 drugs belong to the drug cat-
egories “nervous system,” “anti-infectives for systemic use,” “derma-
tologicals” and “alimentary tract and metabolism.” In 3 out 4 drugs 
is coated tongue a “rare” adverse drug reaction. An overview of all 
drugs that may alter the colour of the tongue is given in Table 3.
3.2 | Increase in volume of the tongue
Tongue oedema was reported in 22 drugs (1.3% of 1645 drugs). 
Tongue oedema was defined as swelling of the tongue due to loss of 
vascular integrity causing extravasation of fluid into interstitial tissue. 
This adverse effect was mentioned in 9 out of 14 ATC level 1 catego-
ries. Occurrence of tongue oedema (Figure 4) was mainly reported 
in the drug category “nervous systems” (45.5%). Frequency of drug-
induced tongue oedema was “common” in 13.6% (3 out of 22 drugs), 
“uncommon” in 31.8% (7 out of 22 drugs), “rare” in 31.8% (7 out of 22 
drugs) and “very rare” in 22.7% (5 out of 22 drugs) of the drugs.
A rare adverse effect of Imipenem is hypertrophy of tongue 
papillae. Imipenem, belonging to the drug category “anti-infectives 
for systemic use,” is the only drug that causes this adverse drug re-
action. An overview of all drugs that may cause tongue oedema and 
hypertrophy of tongue papillae is shown in Table 4.
TA B L E  2   Number of drugs associated with tongue disorders per 
ATC level 1 category
ATC level 1 Category
Drug-induced tongue 
disorders
Alimentary tract and metabolism 13
Anti-infectives for systemic use 35
Antineoplastic and immunomodulating 
agents
11
Antiparasitic products, insecticides and 
repellents
0
Blood and blood-forming organs 2
Cardiovascular system 9
Dermatologicals 6





Systemic hormonal preparations, excl. 1
Various 10
Total: 121
F I G U R E  1   Drug-induced median rhomboid glossitis (B. 
Stegenga, 2013). Reprinted with permission
4  |     AZIZ et Al.
3.3 | Alteration in sensitivity of the tongue
Burning tongue was reported in 10 drugs (0.61% of 1645 drugs) which 
belong to 5 ATC level 1 categories. Burning tongue was defined as 
a burning sensation of tongue caused by drugs without specifying 
the affected region explicitly (Imamura et al., 2019). The appearance 
of the tongue can be changed, but there is no need for an identi-
fiable change in the appearance of the tongue. The drug category 
“alimentary tract and metabolism” (30%) consists of most drugs that 
may cause burning tongue. The frequency of burning tongue was 
“common” in 30% (3 out of 10 drugs), “uncommon” in 20% (2 out of 
10 drugs), “rare” in 10% (1 out of 10 drugs) and “very rare” in 30% (3 
out of 10 drugs) of the drugs. The frequency of burning tongue was 
most frequently (“very common,” 10%) reported for cabozantinib. 
Dysaesthesia of the tongue is an abnormal unpleasant sensation of 
the tongue. This adverse effect was reported for metoclopramide 
and oxaliplatin. These drugs belong to the following drug categories, 
respectively, “alimentary tract and metabolism” and “antineoplastic 
and immunomodulating agents.” Numbness of the tongue was de-
fined as loss of sensation in the tongue not due to peripheral nerve 
injury. Numbness of the tongue was reported in 3 drugs from the 
drug category “nervous system.” The frequency of this adverse drug 
reaction is uncommon. Pruritus of tongue was defined as an itchy 
sensation of the tongue as a result of exposure to medications. It 
was only reported for allergen extracts and was a common side ef-
fect of sublingually administrated allergen extracts. Glossodynia was 
described as burning sensation of the tongue due to an identifiable 
cause, viz., drugs. Glossodynia was reported in 6 drugs (0.36% of 
1645 drugs) in the following drug categories; “anti-infectives for sys-
temic use” (33.3%), “antineoplastic and immunomodulating agents” 
(33.3%), “cardiovascular system” (16.7%) and “various” (16.7%). The 
frequency of glossodynia was “common” in the drug categories “anti-
infectives for systemic use” and “various” (3 out of 6 drugs). In the 
drug categories “antineoplastic and immunomodulating agents” and 
"cardiovascular system" was the frequency "very rare" (3 out of 6 
drugs). Table 5 gives an overview of all drugs that may cause altera-
tion in sensitivity of the tongue.
3.4 | Defect of surface of the tongue
Four drugs are reported to cause ulceration of the tongue (0.30% 
of 1645 drugs). These drugs belong to the following drug cate-
gories: “antineoplastic and immunomodulating agents” (1 drugs), 
"cardiovascular system" (1 drug) and "nervous system” (2 drugs). 
The frequency of tongue ulceration was "rare" in 3 out of 4 drugs 
(Table 6).
3.5 | Other tongue disorders
Unspecified tongue disorders were reported in 5 drugs (0.30% 
of 1645 drugs) in the following drug categories: “nervous sys-
tem” (2 drugs), “antineoplastic and immunomodulating agents” (1 
drug), “anti-infectives for systemic use” (1 drug) and “various” (1 
drug). The frequency of tongue disorders NOS was “common” in 
20% (1 out of 5 drugs), “uncommon” in 40% (2 out of 5 drugs) and 
“unknown” in 40% (2 out of 5 drugs) of these drugs. Iloprost and 
cholestyramine were reported to cause irritation of the tongue. 
They pertain to the drug category, respectively, “blood and blood-
forming organs” and “cardiovascular system.” An overview of all 
drugs that may cause irritation of the tongue and tongue disorders 
NOS can be found in Table 7.
F I G U R E  2   Chlorhexidine-induced tongue discoloration (B. 
Stegenga, 2013). Reprinted with permission
F I G U R E  3   Antibiotic-induced hairy tongue




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8  |     AZIZ et Al.
4  | DISCUSSION
Drug-induced tongue disorders were reported in 7.4% (121/1645) of 
the drugs used in the Netherlands. It was reported in all ATC level 
1 drug categories except the drug category “antiparasitic products, 
insecticides and repellents.” We assume that many oral health-
care providers are confronted with patients that suffer from drug-
induced tongue disorders. Patients using drug from the categories 
“anti-infectives for systemic use” and “nervous system” are more 
likely to endure drug-induced tongue disorders.
As far as we know, this is the first article that gives a compendi-
ous overview of drug-induced tongue disorders. Most of the articles 
on this topic are case reports on one particular drug and adverse 
drug reaction. Till date, there is no study performed that gives a 
complete overview of drugs that cause tongue disorders. An im-
portant note is that the adverse effects reported in our study are 
not just derived from randomized controlled trials, which bears the 
hazard of underreporting, but from a mixture of clinical studies and 
case reports. Furthermore, the data on adverse effects are also ex-
tracted from scientific drug information, guidelines and summaries 
of product characteristics as well as that our study contains entries 
from LAREB. As the information on adverse drug effects originates 
from different sources, the hazard of underreporting and inaccurate 
reporting is minimized in this study.
The drug-induced tongue disorders reported in the literature are 
often not well-defined or a wide range of terminology is used to de-
scribe a particular disorder and vice versa. For example, the term 
glossitis indicates a variety of tongue diseases. Depending upon the 
underlying cause and symptoms, it can refer to atrophic glossitis or 
median rhomboid glossitis or benign migratory glossitis or herpetic 
geometric glossitis, etc. Moreover, tongue conditions like candidiasis 
or tongue soreness caused by burning mouth syndrome can easily be 
labelled as glossitis due to their broadly similar clinical presentation 
and symptoms. As it is not possible to identify the exact definitions 






















































































































































































































































































































































































































































































































































































F I G U R E  4   ACE inhibitor-induced tongue oedema





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12  |     AZIZ et Al.
disorders using the most common definitions. Furthermore, to as-
sure data uniformity we standardized the data by using the ATC and 
MedDRA classification. The use of ATC and MedDRA classification 
makes our data internationally applicable. As mentioned in the first 
article of this series, it is recommended to use MedDRA classifica-
tion for homogenous data collection. We assume that it will improve 
recording of adverse drug reactions in the future. As discussed in 
the first article, there will be drugs that are not mentioned in this 
paper due to difference in local law and regulations on drug per 
country. But most of the drugs mentioned in this study are available 
in European countries.
In the recent years, several studies have reported cases of 
drug-induced tongue disorders. Drugs like angiotensin-converting 
enzyme (ACE) inhibitors(Leung et al., 2012; Stallone et al., 2004), 
non-steroidal anti-inflammatory drugs (NSAIDs) aspirin and certain 
antibiotics are reported to cause angioedema of the lips, tongue and 
face. About 25%-40% of angioedema in orofacial region are induced 
by ACE inhibitors. Perindopril is one of the ACE inhibitors that is 
often associated with angioedema of the lips and tongue. The un-
derlying mechanism for ACE inhibitor-induced angioedema is the 
enzymatic inhibition of bradykinin degradation (Alharbi et al., 2018). 
Early recognition of drug-induced tongue oedema is important as it 
can be a life-threatening condition. In this study, tongue oedema was 
reported in 22 drugs, mainly in the drug category “nervous systems” 
(45.5%). Fosinopril was the only ACE inhibitor that was reported to 
cause tongue oedema. Contrary to expectations, the frequency of 
fosinopril-induced tongue oedema was very rare (˂0.01%). This dis-
crepancy could be explained by the fact that other studies report 
on all cases of ACE inhibitor-induced angioedema in the orofacial 
region. They do not subdivide the orofacial angioedema into differ-
ent categories. In this study, however, the focus lied solely on the 
tongue oedema.
Drugs such as tetracycline, penicillins, anticholinergics and 
linezolid are reported to cause black hairy tongue (Balaji et al., 
2014; Braggio et al., 2018; Gurvits & Tan, 2014; Reamy et al., 
2010). Beside the colour black, hairy tongue can also be yellow, 
green, blue, brown or even colourless. Generally, no treatment 
is necessary for this condition as it is predominantly asymptom-
atic. The pathophysiology of drug-induced black hairy tongue is 
still unknown. In this study, hairy tongue as an adverse effect was 
reported for 4 drugs: metronidazole, hydrogen peroxide, antibi-
otics in combination with amoxicillin and sulphamethoxazole and 
trimethoprim. On the other hand, 21 drugs were associated with 
the development of tongue discoloration as an adverse drug reac-
tion. As expected, most of the drugs were antibiotics. The differ-
ence is likely due to categorizing the tongue disorders by using the 
MedDRA classification and ATC codes. In order to collect homog-
enous data on adverse drug reactions, MedDRA classification is 
recommended to be used.
The occurrence of severe glossitis after administration of 
sulphanilamide and sulphathiazole has been reported in the lit-
erature. The underlying mechanism for glossitis in those cases 
































































































































































































































































































































































































































































































































































































     |  13AZIZ et Al.
present study, glossitis was one of the most frequent adverse ef-
fects of drugs. The drug categories “anti-infectives for systemic 
use” and “nervous systems” contained most of the medications 
that can induce glossitis. Nonetheless, both medications are not 
mentioned in the drug category “anti-infectives for systemic use.” 
The reason could be difference in local law and regulations on 
drug per country. Both antibiotics are not registered in the “far-
macotherapeutisch kompas.” Farmacotherapeutisch kompas is an 
online database in Dutch (FK, 2019) which consist all the med-
ications registered with the Medicines Evaluation Board of the 
Netherlands. In addition, it also consists drugs that are registered 
in European Medicines Agency.
Antirheumatic drugs such as leflunomide are reported to cause 
ulcers in the tongue (Kalogirou et al., 2017). Tongue ulcers are also 
associated with nicorandil use. The pathophysiology of nicorandil-in-
duced tongue ulcers is still unclear (Healy et al., 2004). These ulcers 
usually heal after the discontinuation of the drugs. In the present 
study, four drugs were reported to cause ulceration of the tongue: 
alemtuzumab, nicorandil, melatonin and sertraline. Contrary to the 
literature, tongue ulceration was not reported for leflunomide. Our 
study might underreport some adverse drug reactions compared to 
another studies which are not based on MedDRA classification. The 
LLT term used to categorize the drug-induced tongue disorders is 
very specific. According to the farmacotherapeutisch kompas, an ad-
verse effect of leflunomide is ulcers in the mouth which is unspecific 
compared to tongue ulceration.
5  | CONCLUSION
The growing use of drugs is accompanied by a more frequent 
observation of tongue disorders that may have been induced by 
the use of drugs. As mentioned before, a wide variety of, partly 
overlapping, terminology is found in the literature to describe a 
particular tongue disorder related to the use of a drug and vice 
versa. The terminology used in this paper might help to bring the 
terminology used in pharmacology and oral medicine more in line. 
The overview of drugs reported in this paper helps oral healthcare 
workers in the recognition, diagnosis and eventual treatment of 
drug-induced tongue disorders.
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